Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Presentation

Rhea-AI Summary

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a leading platform for cell programming and biosecurity, has announced its plans to host a presentation and Q&A session to review its second quarter 2024 business performance. The event is scheduled for Thursday, August 8, 2024, at 5:30 p.m. ET, following the market close. Investors and interested parties can access the presentation details and webcast link on Ginkgo's investor relations website. A replay of the session will be made available afterwards.

To facilitate engagement, Ginkgo is encouraging participants to submit questions in advance. Questions can be posted on X (formerly Twitter) using the hashtag #GinkgoResults or sent via email to investors@ginkgobioworks.com.

News Market Reaction

-2.63%

1 alert

-2.63% News Effect

On the day this news was published, DNA declined 2.63%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Presentation and Q&A session scheduled for post-market on Thursday, August 8, 2024

BOSTON, Aug. 1, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2024, on Thursday, August 8, 2024, beginning at 5:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com 

MEDIA CONTACT:

press@ginkgobioworks.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-second-quarter-2024-results-presentation-302210211.html

SOURCE Ginkgo Bioworks

FAQ

When will Ginkgo Bioworks (DNA) release its Q2 2024 earnings?

Ginkgo Bioworks (DNA) will host its Q2 2024 earnings presentation and Q&A session on Thursday, August 8, 2024, at 5:30 p.m. ET, after the market closes.

How can I access Ginkgo Bioworks' (DNA) Q2 2024 earnings presentation?

The presentation details and webcast link for Ginkgo Bioworks' Q2 2024 earnings will be available on the company's investor relations website at https://investors.ginkgobioworks.com.

Can I submit questions for Ginkgo Bioworks' (DNA) Q2 2024 earnings call?

Yes, you can submit questions for Ginkgo Bioworks' Q2 2024 earnings call by posting on X (Twitter) using the hashtag #GinkgoResults or by emailing investors@ginkgobioworks.com.

Will there be a replay available for Ginkgo Bioworks' (DNA) Q2 2024 earnings call?

Yes, Ginkgo Bioworks (DNA) will make a replay of the Q2 2024 earnings presentation and Q&A session available on their investor relations website.